In this work we synthesized new derivatives from Phenyl Hydrazine and series of different Aldehydes (derivatives of benzylidenes). The synthesized compounds contain different aromatic Aldehydes which attached by Benzene ring via Hydrazine moiety in glacial acetic acid. These derivatives were characterized by TLC, melting points, Infrared Red, Proton Nuclear Magnetic Resonance, Carbon Thirteen Nuclear Magnetic Resonance and Mass Spectroscopy. Finally, these synthesized derivatives were tested for antiproliferative activity against multiple normal and cancerous cell lines, HepG2 (Liver cancer) and MCF-7 (Breast cancer) cell lines were used for cytotoxic assay.
International Agency for Cancer Research and World Health Organization (2014) World Cancer Factsheet 2014.
[3]
Bridges, A.J. (2001) Chemical Inhibitors of Protein Kinases. Chemical Reviews, 101, 2541-2572. https://doi.org/10.1021/cr000250y
[4]
Wang, J.D., Miller, K., Boschelli, D.H., Ye, F., Wu, B., Floyd, M.B., Powell, D.W., Wissner, A., Weber, J.M. and Boschelli, F. (2000) Inhibitors of Src Tyrosine Kinase: The Preparation and Structure-Activity Relationship of 4-Anilino-3-Cyanoquinolines and 4-Anilinoquinazolines. Bioorganic & Medicinal Chemistry Letters, 10, 2477-2480. https://doi.org/10.1016/S0960-894X(00)00493-5
[5]
Cai, S.X. (2007) Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment. Recent Patents on Anti-Cancer Drug Discovery, 2, 79-101. https://doi.org/10.2174/157489207779561462
[6]
Shi, L.M., Fan, Y., Lee, J.K., Waltham, M., Andrews, D.T., Scherf, U., Paull, K.D. and Weinstein, J.N. (2000) Mining and Visualizing Large Anticancer Drug Discovery Databases. Journal of Chemical Information and Modeling, 40, 367-379. https://doi.org/10.1021/ci990087b
[7]
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Wolff, V.A., Goodrich, M.G., Campbell, H., Mayo, J. and Boyd, M.J. (1991) Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. JNCI: Journal of the National Cancer Institute, 83, 757-766. https://doi.org/10.1093/jnci/83.11.757
[8]
Palmer, B.D., Rewcastle, G.W., Atwell, G.J., Baguley, B.C. and Denny, W.A. (1988) Potential Antitumor Agents. 54. Chromophore Requirements for in Vivo Antitumor Activity among the General Class of Linear Tricyclic Carboxamides. Journal of Medicinal Chemistry, 31, 707-712. https://doi.org/10.1021/jm00399a003
[9]
Denny, W.A., Rewcastle, G.W. and Baguley, B.C. (1990) Potential Antitumor Agents. 59. Structure-Activity Relationships for 2-Phenylbenzimidazole-4-Carboxamides, a New Class of Minimal DNA-Intercalating Agents Which May Not Act via Topoisomerase II. Journal of Medicinal Chemistry, 33, 814-819. https://doi.org/10.1021/jm00164a054
[10]
Sakr, H.M., Ayyad R.R., Mahmoud, K., Mansour, A.M. and Ahmed, A.G. (2021) Design Synthesis of Analgesics and Anticancer of Some New Derivatives of Benzimidazole. International Journal of Organic Chemistry, 11, 144-169. https://doi.org/10.4236/ijoc.2021.113011
[11]
Khalifa, M.M., Sakr, H.M., Ibrahim, A., Mansour A.M. and Ayyad R.R. (2022) Design and Synthesis of New Benzylidene-Quinazolinone Hybrids as Potential Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, and Docking Studies. Journal of Molecular Structure, 1250, Article ID: 131768. https://doi.org/10.1016/j.molstruc.2021.131768
[12]
El-Helby, A., Sakr, H.M., Ayyad R.R., Mahdi, H., Khalifa, M.M., Belal, A., et al. (2020) Design, Synthesis, Molecular Modeling, in Vivo Studies and Anticancer Activity Evaluation of New Phthalazine Derivatives as Potential DNA Intercalators and Topoisomerase II Inhibitors. Bioorganic Chemistry, 103, Article ID: 104233. https://doi.org/10.1016/j.bioorg.2020.104233
[13]
Ayyad, R.R. (2012) Synthesis and Biological Evaluation of Novel Iodophthalazinedione Derivatives as Anticonvulsant Agents. Al-Azhar Journal of Pharmaceutical Sciences, 45, 1-13. https://doi.org/10.21608/ajps.2012.7146
[14]
El-Dehna, W.M. Abou-Seri, S., El-Kerdawy, A., Ayyad, R.R., et al. (2016) Increasing the Binding Affinity of VEGFR-2 Inhibitors by Extending Their Hydrophobic Interaction with the Active Site: Design, Synthesis and Biological Evaluation of 1-Substituted-4-(4-Methoxybenzyl) Phthalazine Derivatives. European Journal of Medicinal Chemistry, 113, 50-62. https://doi.org/10.1016/j.ejmech.2016.02.029
[15]
El-Helby, A., Ayyad, R.R., Sakr, H.M., Abdul-Rahim, A.S., et al. (2017) Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel 2,3-Dihydrophthalazine-1,4-Dione Derivatives as Potential Anticonvulsant Agents. Journal of Molecular Structure, 1130, 333-351. https://doi.org/10.1016/j.molstruc.2016.10.052
[16]
El-Helby, A., Ayyad, R.R., Sakr, H.M., El-Adl, K., Ali, M.M. and Khedr, F. (2017) Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR-2 Inhibitors. Archiv der Pharmazie, 350, Article ID: 1700240. https://doi.org/10.1002/ardp.201700240
[17]
El-Helby, A., Ayyad, R.R., El-Adl, K. and El-Kady, H. (2019) Phthalazine-1,4-Dione Derivatives as Non-Competitive AMPA Receptor Antagonists: Design, Synthesis, Anticonvulsant Evaluation, ADMET Profile and Molecular Docking. Molecular Diversity, 23, 283-298. https://doi.org/10.1007/s11030-018-9871-y
[18]
Eissa, I.H., Metwally, A.M., Belal, A. and Mehany, A.B. (2019) Discovery and Antiproliferative Evaluation of New Quinoxalines as Potential DNA Intercalators and Topoisomerase II Inhibitors. Archiv der Pharmazie, 352, Article ID: 1900123. https://doi.org/10.1002/ardp.201900123
[19]
Kamal, I.M., Abdul-Rahman, A.A., Ayyad R.R. and El-Adl, K. (2013) Design and Synthesis of Some Novel 2-(3-Methyl-2-Oxoquinoxalin-1(2H)-yl)-N-(4-(substituted)-Phenyl) Acetamide Derivatives for Biological Evaluation as Anticonvulsant Agents. Bulletin of Faculty of Pharmacy, Cairo University, 51, 101-111. https://doi.org/10.1016/j.bfopcu.2012.11.003
[20]
El-Helby, A., Ayyad, R.R. and Zayed, M.F. (2011) Synthesis and Biological Evaluation of Some Novel Quinoxaline Derivatives as Anticonvulsant Agents. Arzneimittelforschung, 61, 379-381. https://doi.org/10.1055/s-0031-1296214
[21]
El-Helby, A., Ayyad R.R., El-Adl, K. and Elwan, A. (2017) Quinoxalin-2(1H)-One Derived AMPA-Receptor Antagonists: Design, Synthesis, Molecular Docking and Anticonvulsant Activity. Medicinal Chemistry Research, 26, 2967-2984. https://doi.org/10.1007/s00044-017-1996-5
[22]
El-Helby, A., Ayyad R.R., Zayed, M.F. and Abou-El-Kheer, H.S. (2019) Design, Synthesis, in Silico ADMET Profile and GABA-A Docking of Novel Phthalazines as Potent Anticonvulsants. Archiv Der Pharmazie, 352, Article ID: 1800387. https://doi.org/10.1002/ardp.201800387
[23]
El-Helby, A., Ayyad, R.R., Sakr, H.M. and El-Adl, K. (2018) Design, Synthesis, in Vitro Anti-Cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo [3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. Anti-Cancer Agents in Medicinal Chemistry, 18, 1184-1196. https://doi.org/10.2174/1871520618666180412123833
[24]
Ekhlass, M.N., Abdul Razek F.M., Ayyad R.R. and El-Farargy, A.F. (2016) Synthesis and Some Reactions of 1-Aryl-4-Acetyl-5-Methyl-1, 2, Triazole Derivatives with Anticonvulsant Activity. Mini-Reviews in Medicinal Chemistry, 16, 926-936.
[25]
Ayyad, R.R. (2014) Synthesis and Anticonvulsant Activity of 6-Iodo Phthalazinedione Derivatives. Al-Azhar Journal of Pharmaceutical Sciences, 50, 43-54. https://doi.org/10.21608/ajps.2016.6930
[26]
El-Helby, A. Ibrahim, M.K., Abdul Rahman, A.A., Ayyad, R.R., Menshawy, M.A. and El-Adl, K. (2009) Synthesis, Molecular Modeling and Anticonvulsant Activity of Benzoxazole Derivatives. Al-Azhar Journal of Pharmaceutical Sciences, 40, 252-270.
[27]
Ayyad, R.R., Sakar, H.M. and El-Gammal, K. (2016) Synthesis, Modeling and Anticonvulsant Activity of Some Phthalazinedione. American Journal of Organic Chemistry, 6, 29-38.
[28]
Ayyad, R.R. (2008) Synthesis and Anticonvulsant Activity of Tetrabromophthalazinedione. Al-Azhar Journal of Pharmaceutical Sciences, 50, 33-45.
[29]
El-Helby, A., Ibrahim, M.K., Amin, M.A. and Ayyad, R.R. (2020) Synthesis and Anticonvulsant Activity of Phthalazindione Derivatives. Al-Azhar Journal of Pharmaceutical Sciences, 28, 22-35.
[30]
Ibrahim, M.K., Abdel-Rahman A.A., Ayyad, R.R., El-Adl, K., El-Sherbeny, F. and Rashed, M. (2010) Design and Synthesis of Some Novel N-Phthalimide Derivatives with Potential Anticonvulsant Activity. Al-Azhar Journal of Pharmaceutical Sciences, 42, 305-322.
[31]
Alaa, A.M., Abou-Zeid, L.A., El-Tahir, K.H., Ayyad, R.R., Magda, A.A. and El-Azab, A.S. (2016) Synthesis, Anti-Inflammatory, Analgesic, COX-1/2 Inhibitory Activities and Molecular Docking Studies of Substituted 2-Mercapto-4(3H)-Quinazolinones. European Journal of Medicinal Chemistry, 121, 410-421. https://doi.org/10.1016/j.ejmech.2016.05.066
[32]
Menshawy, M.A., Ayyad, R.R., Shawer, T.Z. and Alaa, A.M. (2016) Synthesis and Antitumor Evaluation of Trimethoxyanilides Based on 4(3H)-Quinazolinone Scaffolds. European Journal of Medicinal Chemistry, 112, 106-113. https://doi.org/10.1016/j.ejmech.2016.02.002
[33]
Hall, J.H., Hall, E.S. and Wong, O.T. (1992) Cumulated Index Medicus. Anti-Cancer Drug, 3, 55-62. https://doi.org/10.1097/00001813-199202000-00010
[34]
Soje-Echaque, E. and Lim, R.K. (1962) Inflammation and Anti-Inflammatories. Spectrum, New York, USA. Journal of Pharmacology and Experimental Therapeutics, 49, 138-224.
[35]
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J. and Vistica, D. (1990) New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. JNCI: Journal of the National Cancer Institute, 82, 1107-1112. https://doi.org/10.1093/jnci/82.13.1107
[36]
Allam, R.M., Al-Abd, A.M., Khedr, A. and Sharaf, O.A. (2018) Fingolimod Interrupts the Cross Talk between Estrogen Metabolism and Sphingolipid Metabolism within Prostate Cancer Cells. Toxicology Letters, 291, 77-85. https://doi.org/10.1016/j.toxlet.2018.04.008
